According to Fortune Business Insights, the peripheral vascular devices market was valued at approximately USD 12.04 billion in 2025 and is projected to reach USD 19.42 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 5.5% during the forecast period.
The global peripheral vascular devices market is witnessing steady expansion, driven by the increasing prevalence of peripheral artery disease (PAD), technological advancements in minimally invasive procedures, and growing awareness regarding early vascular interventions.
Peripheral vascular devices are medical tools used to diagnose and treat vascular diseases occurring outside the heart and brain, primarily in the legs and arms. These devices help restore blood flow in blocked or narrowed arteries and veins and are essential in treating conditions such as PAD, deep vein thrombosis (DVT), and other circulatory disorders. The market includes angioplasty balloons, stents, catheters, guidewires, atherectomy devices, and thrombus management systems.
Information Source: https://www.fortunebusinessinsights.com/peripheral-vascular-devices-market-115399
Market Drivers
Rising Prevalence of Peripheral Artery Disease
One of the primary factors driving market growth is the increasing global burden of PAD. Aging populations, combined with rising incidences of diabetes, obesity, smoking, and hypertension, significantly increase the risk of vascular disorders. As the global elderly population continues to expand, the number of individuals requiring vascular interventions is also rising, thereby boosting demand for peripheral vascular devices.
Growing Preference for Minimally Invasive Procedures
Minimally invasive endovascular treatments are increasingly preferred over open surgeries due to shorter hospital stays, faster recovery times, reduced complications, and lower healthcare costs. Advancements in catheter-based procedures and imaging technologies have made these treatments safer and more effective. This shift toward less invasive procedures is significantly contributing to the adoption of peripheral vascular devices worldwide.
Technological Advancements and Product Innovations
Continuous innovation in device design and materials is another key growth factor. Drug-eluting stents, bioresorbable scaffolds, next-generation balloons, and advanced atherectomy systems are improving clinical outcomes. Enhanced imaging integration and navigation systems allow physicians to perform complex interventions with greater precision. Regulatory approvals of new products and expansion of clinical indications are further accelerating market growth.
Market Segmentation Insights
The market is segmented based on device type, end-user, and region.
By device type, angioplasty balloons and stents hold a significant share due to their widespread use in treating arterial blockages. Atherectomy devices and thrombectomy systems are also gaining traction as they provide effective solutions for removing plaque and blood clots.
In terms of end-users, hospitals account for the largest market share, as they handle a high volume of vascular procedures and are equipped with advanced interventional facilities. Ambulatory surgical centers are also experiencing growth due to cost-effectiveness and increasing patient preference for outpatient procedures.
Regional Analysis
North America
North America dominates the global peripheral vascular devices market, accounting for the largest revenue share. The region benefits from advanced healthcare infrastructure, favorable reimbursement policies, and early adoption of innovative technologies. A high prevalence of PAD and other vascular disorders in the United States further supports market expansion.
Europe